Intradermal Versus Intramuscular Hepatitis B Vaccination in Hemodialysis Patients: A Prospective Open-Label Randomized Controlled Trial in Nonresponders to Primary Vaccination
- 31 July 2009
- journal article
- research article
- Published by Elsevier BV in American Journal of Kidney Diseases
- Vol. 54 (1), 95-103
- https://doi.org/10.1053/j.ajkd.2009.03.010
Abstract
No abstract availableThis publication has 38 references indexed in Scilit:
- Low Dose Intradermal Vaccination Is Superior to High Dose Intramuscular Vaccination for Hepatitis B in Unresponsive Hemodialysis PatientsRenal Failure, 2007
- Meta‐analysis: intradermal vs. intramuscular vaccination against hepatitis B virus in patients with chronic kidney diseaseAlimentary Pharmacology & Therapeutics, 2006
- Antibody Response to Hepatitis B Vaccine in End-Stage Renal Disease PatientsNephron Clinical Practice, 2006
- Hepatitis B vaccination for patients with chronic renal failureEmergencias, 2004
- Special Article: National Surveillance of Dialysis‐Associated Diseases in the United States, 2001Seminars in Dialysis, 2004
- Intradermal Recombinant Hepatitis B Vaccine for Healthcare Workers Who Fail to Respond to Intramuscular VaccineInfection Control & Hospital Epidemiology, 2002
- INTERFERON AND HEPATITIS B VACCINE IN HAEMODIALYSIS PATIENTSThe Lancet, 1989
- Controlled Trial of Thymopentin in Hemodialysis Patients Who Fail to Respond to Hepatitis B VaccinationNephron, 1988